Villaroya, Guillerma O.

HRN: 19-46-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2022
CEFTRIAXONE 1G (VIAL)
11/23/2022
11/29/2022
IV
2g
OD
DM Foot, Left
Waiting Final Action 
11/23/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/23/2022
11/29/2022
IV
600mg
Q8
DM Foot
Waiting Final Action 
12/09/2022
CEFTRIAXONE 1G (VIAL)
12/09/2022
12/16/2022
IVT
2g
OD
DM Foot Left Wagner Classification Grade III
Waiting Final Action 
12/09/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/09/2022
12/19/2022
IVT
600mg
Q6
DM Foot Left Wagner Classification Grade III;
Waiting Final Action 
12/16/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/16/2022
12/22/2022
IV
4.5g
Q6
Cellulitis; Sepsis
Waiting Final Action 
12/17/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/17/2022
12/19/2022
IV
600mg
Q6
Sepsis, DM Foot, Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: